Vitamin D receptor polymorphisms are associated with Graves' disease in German and Polish but not in Serbian patients

被引:45
作者
Ramos-Lopez, E
Kurylowicz, A
Bednarczuk, T
Paunkovic, J
Seidl, C
Badenhoop, K
机构
[1] Univ Hosp Frankfurt, Div Endocrinol, Dept Internal Med 1, D-60590 Frankfurt, Germany
[2] Polish Acad Sci, Med Res Ctr, Dept Endocrinol, Warsaw, Poland
[3] Med Ctr Zajecar, Dept Nucl Med, Zajecar, Serbia Monteneg
[4] Red Cross Blood Transfus Ctr, Inst Transfus & Immunohaematol, Frankfurt, Germany
关键词
D O I
10.1089/thy.2005.15.1125
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diverse genes are candidates for susceptibility to Graves' disease, including the vitamin D receptor (VDR), which regulates the transcription of target genes in response to the active metabolite 1,25(OH)(2)D-3. We analyzed four polymorphisms of the VDR gene (ApaI, TaqI, BsmI, and FokI) in patients with Graves' disease (n = 789) and healthy controls (n = 823) from three European populations (German, Polish, and Serbian). The VDR Apal (rs7975232) and TaqI (rs731236) polymorphisms showed no significant difference in any population. The BsmI (rs1544410) variant "b" was associated with Graves' disease in the Polish population (p = 0.0070). The FokI (rs10735810) variant "f" was found to be associated with Graves' disease in Germans and "F" in Polish patients (p = 0.0024 and 0.0049, respectively). Construction of haplotypes for TaqI, ApaI, and BsmI showed the haplotype "Tab" to be the most frequent in the German and Polish population as well as in the Serbian patients, while "tAB" in Serbian controls. Our results show an association of VDR gene polymorphisms in the German and Polish population but not in the Serbian. Furthermore, the VDR polymorphisms are differentially distributed in the three populations. Therefore, VDR polymorphisms analysis needs to be stratified according to the population background.
引用
收藏
页码:1125 / 1130
页数:6
相关论文
共 30 条
[1]   SUSCEPTIBILITY AND RESISTANCE ALLELES OF HUMAN-LEUKOCYTE ANTIGEN (HLA) DQA1 AND HLA DQB1 ARE SHARED IN ENDOCRINE AUTOIMMUNE-DISEASE [J].
BADENHOOP, K ;
WALFISH, PG ;
RAU, H ;
FISCHER, S ;
NICOLAY, A ;
BOGNER, U ;
SCHLEUSENER, H ;
USADEL, KH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) :2112-2117
[2]   Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population [J].
Ban, Y ;
Taniyama, M ;
Ban, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4639-4643
[3]   Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease [J].
Ban, Y ;
Ban, Y ;
Taniyama, M ;
Katagiri, T .
THYROID, 2000, 10 (06) :475-480
[4]  
Cippitelli M, 1998, EUR J IMMUNOL, V28, P3017, DOI 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.3.CO
[5]  
2-Y
[6]   Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians [J].
Collins, JE ;
Heward, JM ;
Nithiyananthan, R ;
Nejentsev, S ;
Todd, JA ;
Franklyn, JA ;
Gough, SCL .
CLINICAL ENDOCRINOLOGY, 2004, 60 (05) :618-624
[7]   Exclusive underexpression of vitamin D receptor exon If transcripts in tumors of primary hyperparathyroidism [J].
Correa, P ;
Åkerström, G ;
Westin, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (05) :671-675
[8]   INVIVO BENEFICIAL-EFFECTS OF CYCLOSPORINE A AND 1,25-DIHYDROXYVITAMIN-D3 ON THE INDUCTION OF EXPERIMENTAL AUTOIMMUNE-THYROIDITIS [J].
FOURNIER, C ;
GEPNER, P ;
SADOUK, M ;
CHARREIRE, J .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 54 (01) :53-63
[9]   Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese [J].
Furugaki, K ;
Shirasawa, S ;
Ishikawa, N ;
Ito, K ;
Ito, K ;
Kubota, S ;
Kuma, K ;
Tamai, H ;
Akamizu, T ;
Hiratani, H ;
Tanaka, M ;
Sasazuki, T .
JOURNAL OF HUMAN GENETICS, 2004, 49 (03) :166-168
[10]  
Gross C, 1996, J BONE MINER RES, V11, P1850